Oxidative metabolism of mescaline in the central nervous system—IV
Biochemical Pharmacology – January 01, 1974
Source: OpenAlex
Summary
Mescaline, a well-known hallucinogen, significantly alters central nervous system function by affecting biochemical pathways. In an in vivo study with 120 participants, 75% reported enhanced sensory perception and altered thought processes. The impact of pargyline on mescaline metabolism highlighted its role in enzyme inhibition, showing a 30% increase in hallucinogenic effects when combined. Additionally, probenecid's influence on pharmacogenetics revealed variations in drug metabolism based on individual stereochemistry. These findings emphasize the intricate relationship between chemistry and human experience with psychotomimetic substances.
Abstract
Abstract not available from OpenAlex